Reimbursement for Continuous Glucose Monitoring

Diabetes Technology & Therapeutics
Lutz Heinemann, J Hans DeVries

Abstract

Continuous glucose monitoring (CGM) systems have been available for more than 15 years by now. However, market uptake is relatively low in most countries; in other words, relatively few patients with diabetes use CGM systems regularly. One major reason for the reluctance of patients to use CGM systems is the costs associated (i.e., in most countries no reimbursement is provided by the health insurance companies). In case reimbursement is in place, like in the United States, only certain patient groups get reimbursement that fulfills strict indications. This situation is somewhat surprising in view of the mounting evidence for benefits of CGM usage from clinical trials: most meta-analyses of these trials consistently show a clinically relevant improvement of glucose control associated with a reduction in hypoglycemic events. More recent trials with CGM systems with an improved CGM technology showed even more impressive benefits, especially if CGM systems are used in different combinations with an insulin pump (e.g., with automated bolus calculators and low glucose suspend features). Nevertheless, sufficient evidence is not available for all patient groups, and more data on cost-efficacy are needed. In addition, good data from re...Continue Reading

References

Aug 22, 2008·Diabetes Technology & Therapeutics·Irl B HirschBruce A Buckingham
Sep 10, 2008·The New England Journal of Medicine·William V TamborlaneDongyuan Xing
Mar 25, 2010·Diabetes Care·Elbert S HuangUNKNOWN Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
Jul 1, 2010·The New England Journal of Medicine·Richard M BergenstalUNKNOWN STAR 3 Study Group
Feb 8, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·J HermanidesJ H DeVries
Feb 22, 2011·Diabetes Care·Tadej BattelinoJan Bolinder
Aug 11, 2011·Diabetes Technology & Therapeutics·Thomas DanneAndreas Thomas
Oct 7, 2011·The Journal of Clinical Endocrinology and Metabolism·David C KlonoffUNKNOWN Endocrine Society
Jan 9, 2013·Journal of Diabetes Science and Technology·Lutz HeinemannJ Hans Devries
Jun 25, 2013·The New England Journal of Medicine·Richard M BergenstalUNKNOWN ASPIRE In-Home Study Group
Aug 8, 2015·Journal of Diabetes Science and Technology·Lutz Heinemann, Norbert Hermanns

❮ Previous
Next ❯

Citations

Mar 22, 2016·Diabetes, Obesity & Metabolism·H BlauwUNKNOWN , on behalf of the PCDIAB consortium
Jun 7, 2017·Diabetes Technology & Therapeutics·Claudia Graham
May 23, 2018·Journal of Diabetes Science and Technology·Martina VettorettiGiovanni Sparacino
Aug 18, 2017·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Irl B Hirsch, Carol A Verderese
May 19, 2018·Journal of Biomedical Optics·Ramachandram BaduguJoseph R Lakowicz
Feb 18, 2020·Journal of Diabetes Science and Technology·Ralph ZieglerBernd Kulzer
Jan 18, 2018·The Journal of Clinical Endocrinology and Metabolism·Sara CharleerUNKNOWN RESCUE Trial Investigators
Jan 20, 2016·Diabetes Technology & Therapeutics·Satish K Garg
Nov 19, 2018·The American Journal of the Medical Sciences·Guillermo E Umpierrez, Boris P Kovatchev
Oct 26, 2021·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Andrej JanezNataliya Zelinska

❮ Previous
Next ❯

Software Mentioned

FreeStyle
FreeStyle Libre
ASPIRE

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Diabetic Medicine : a Journal of the British Diabetic Association
Lutz Heinemann, J Hans DeVries
International Journal of Clinical Practice. Supplement
John Pickup
Journal of Diabetes Science and Technology
Bruce A Buckingham
© 2022 Meta ULC. All rights reserved